Originally Posted by
Minerbarejet
A little context.
The capacity of the US facility is about 260,000 tests per year.
If they are approaching capacity and need further facilities there then at the rate of 1000 NZD per test there would be getting near 260 million filling the coffers.
If they had that much going through what would be the need for a miniscule 70 million?
Lets not forget they are owed a fair bit from previously done CMS tests - we have no definite answer on that one as yet either.
Personally I think if the document was actually something that will be revealed then it would be either for expansion into Asia or Australia, perhaps both.
Pacific Edge also has a pipeline of other products some of which have been through some clinical trials and are ready to market, if still viable.